Stereotactic Body Radiation Therapy for Hepatocellular Carcinoma
- Status
- COMPLETED
- Phase
- PHASE2
Clinical Trials Related to Hepatocellular Carcinoma
Related studies linked through entity extraction aliases.
Stereotactic Ablative Radiotherapy for Hepatocellular Carcinoma With Major Portal Vein Invasion
- Status
- COMPLETED
- Phase
- PHASE2
Hepatocellular Carcinoma Using Stereotactic Body Radiotherapy
- Status
- UNKNOWN
- Phase
- NA
Sorafenib Plus Doxorubicin in Patients With Advanced Hepatocellular Carcinoma With Disease Progression on Sorafenib
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Transarterial Ethanol Ablation(TEA) for Unresectable Hepatocellular Carcinoma(HCC)
- Status
- COMPLETED
- Phase
- NA
P2 Study of Postoperative Interferon/Fluorouracil vs Cisplatin/Fluorouracil for Hepatocellular Carcinoma.
- Status
- UNKNOWN
- Phase
- PHASE2
Transcatheter Arterial Chemoembolization Combined With Sorafenib for Unresectable Hepatocellular Carcinoma
- Status
- COMPLETED
- Phase
- PHASE3
TACE+RFA Versus Re-resection for Recurrent Small Hepatocellular Carcinoma
- Status
- UNKNOWN
- Phase
- PHASE3
Stereotactic Ablative Radiotherapy for Hepatocellular Carcinoma ≤ 5 cm
- Status
- UNKNOWN
- Phase
- PHASE2
Stratification of Patients With Chronic Liver Disease Using Multi Spectral CT
- Status
- COMPLETED
- Phase
- N/A
Combined Chemoembolization and Systemic Hyperthermia for Unresectable Hepatocellular Carcinoma
- Status
- TERMINATED
- Phase
- NA
DCE-MRI Using Dotarem® in Evaluation of Therapeutic Response to Sorafenib in Patients With Advanced Stage HCC
- Status
- TERMINATED
- Phase
- PHASE4
Civacir® Polyclonal Immune Globulin (IgG) to Prevent Hepatitis C Virus (HCV) Recurrence in Liver Transplant Patients.
- Status
- COMPLETED
- Phase
- PHASE3
A Phase Ib Study of Stereotactic Body Radiotherapy (SBRT) Plus Sorafenib in Patients With Unresectable Hepatocellular Carcinoma (HCC)
- Status
- WITHDRAWN
- Phase
- PHASE1
Selective Internal Radiation Therapy (SIRT) Versus Transarterial Chemoembolisation (TACE) for the Treatment of Hepatocellular Carcinoma (HCC).
- Status
- COMPLETED
- Phase
- PHASE4
Microparticle Enhanced Cytotoxic Transarterial Embolization Therapy in Hepatocellular Carcinoma
- Status
- COMPLETED
- Phase
- NA
Body Composition Analysis in Patients Undergoing Chemoembolization
- Status
- COMPLETED
- Phase
- N/A
Response of Hepatic Tumors to Radioembolization
- Status
- WITHDRAWN
- Phase
- PHASE2
Laparoscopic Versus Open Liver Resection in the Treatment of Hepatocellular Carcinoma
- Status
- UNKNOWN
- Phase
- NA
Utility Study of Primovist-MRI on HCC Staging
- Status
- UNKNOWN
- Phase
- N/A